Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Gentle ear vagus nerve stimulation to reduce headache after aneurysm stent coiling

Official title: Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation for Postoperative Headache Following Stent-Assisted Coiling of Unruptured Intracranial Aneurysms

Run by Beijing Tiantan Hospital · NCT07479082 · Data updated 2026-11-12

This study will try a noninvasive ear vagus nerve stimulation device to see if it reduces postoperative headaches in adults having stent-assisted coiling or flow-diverter treatment for unruptured brain aneurysms.

More Headache trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment440 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedSeptember 30, 2025
Main results expectedJuly 2027
Study endsJuly 2027
Registry record updatedMarch 18, 2026
Trial IDNCT07479082 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–80 with imaging-confirmed unruptured intracranial aneurysms who are scheduled for stent-assisted coiling or flow-diverter embolization and can give informed consent are ideal candidates.

Probably not a fit

Patients with primary chronic headache disorders, prior seizures or vagotomy, implanted electronic devices, significant cardiac instability, skin lesions at the ear site, pregnancy, or other listed exclusions are not eligible and unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults aged 18–80 scheduled for stent-assisted coiling or flow-diverter embolization for unruptured intracranial aneurysms are randomized to receive active transcutaneous auricular vagus nerve stimulation (taVNS) or a sham placement. Participants begin wearing the device one day before the procedure and continue per protocol, with the active device placed on the left earlobe and the sham on the cymba conchae. The study compares incidence of headache within 90 days and use of analgesic medications between groups and monitors safety and tolerability. The trial is conducted at Capital Medical University Affiliated Beijing Tiantan Hospital as a single-center interventional study.

Why it matters

Potential benefit: If successful, taVNS could lower the frequency and severity of headache after aneurysm stent procedures and reduce the need for pain medications.

How similar studies have gone: Small pilot trials of taVNS have shown promise for some headache and pain conditions, but using taVNS specifically to prevent postoperative headache after aneurysm coiling is a relatively novel application with limited prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18-80 years
2. Diagnosed with unruptured intracranial aneurysm confirmed by imaging
3. Planned to undergo stent-assisted coiling or flow diverter embolization
4. Signed informed consent

Exclusion Criteria:

1. History of SAH, ICH, brain tumor, major trauma, substance abuse, syncope, or seizures
2. Recurrent/traumatic/infectious/myxomatous aneurysms
3. Primary headache disorders (e.g., migraine, cluster headache, trigeminal neuralgia) not attributed to UIA
4. Previous vagotomy, migraine surgery, or implanted neurostimulators
5. Other concurrent electronic/implantable devices (e.g., pacemakers, neurostimulators)
6. Clinically significant hypotension, congenital heart disease, severe arrhythmia, unstable angina, or recent MI
7. Inability to follow up due to severe psychiatric disorder or refusal
8. Skin lesions at taVNS placement site
9. Pregnant or lactating
10. Participation in other trials

Where it's running

  • Capital Medical University Affiliated Beijing Tiantan Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.